European patent protection for medical uses of known products and drug repurposing
Obtaining European patent protection for medical uses of known products is not a key factor limiting repurposing activity.
Mapping the European Patent Landscape for Medical Uses of Known Products
European Patent Office (EPO) data show an increasing number of patents for new medical uses of known products
How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers; nature-based products; diagnostics; and algorithms, big data and AI?
Behind the paper "How does the emerging patent case law in the US and Europe affect precision medicine?"